Plain-English translation of NCT04351347 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This clinical trial is testing — a medication that's been used for other conditions — at higher doses to see if it can effectively treat COVID-19. Researchers want to compare how well this medication works compared to standard COVID-19 care. The study is enrolling 300 patients to answer this question.
During the COVID-19 pandemic, doctors and researchers searched for new treatment options to help patients recover faster and more effectively. This trial is exploring whether this medication at higher doses might be a helpful addition to current treatment approaches.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the higher-dose medication or the standard COVID-19 treatment that doctors normally provide. Researchers will monitor how well the treatment works and check for any side effects. The study involves visits where your health will be assessed and your response to treatment will be tracked.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Egypt